IndiaOne Finance - Company Dashboard

Governance Classic Home

Concord Biotech LtdPharmaceuticalsINE338H01029Consolidated₹1493.90+31.80 (+2.17%)Jun-26

Valuation

Market Cap₹15.63K Cr

TTM PE57.28x

Forward PE55.87x

PEG10.83

Book Value₹192.81

P/B7.75x

TTM EPS₹26.09

Fwd EPS₹26.75

TTM Revenue₹1.11K Cr

TTM PAT₹272.87 Cr

TTM EBITDA₹388.38 Cr

TTM EBIT₹313.60 Cr

Last Qtr PAT₹57.70 Cr

Last Qtr EBITDA₹82.38 Cr

Last Qtr EBIT₹64.28 Cr

Profitability

ROE13.53%

ROCE17.92%

TTM NPM24.62%

TTM EBITDA %35.04%

Curr OPM21.35%

Last OPM25.91%

Curr NPM—

Last NPM—

Curr EPS₹5.52

Last EPS₹8.46

Balance sheet

Equity₹10.46 Cr

Reserve₹2.01K Cr

Total Debt₹2.31 Cr

D/E0.00x

Interest %0.07%

Curr Interest₹0.04 Cr

Price / range

Close₹1494.40

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+2.28%

1W-0.85%

1M-4.65%

3M+11.32%

6M+30.88%

1Y-9.75%

2Y-31.62%

3Y—

5Y—

Diwali+11.77%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	260.52+27.7%	325.89	278.13	247.06	203.99	1,055.07
Other Income	13.10	15.54	10.08	13.43	13.68	52.73
Total Income	273.61+25.7%	341.43	288.22	260.49	217.67	1,107.80
Interest	0.02	0.06	0.06	0.06	0.06	0.23
Expenditure	-191.40-19.3%	-223.06	-194.64	-174.97	-160.43	-753.09
PBDT	0	0	0	0	0	0
EBITDA	87.19+42.0%	122.38	102.22	90.54	61.40	376.54
Depreciation	-18.05	-19.49	-18.67	-18.39	-17.78	-74.33
EBIT	69.14+58.5%	102.89	83.55	72.15	43.62	302.21
PBT	82.21+43.6%	118.38	90.30	85.52	57.24	351.43
Tax	-21.02	-28.36	-22.51	-22.62	-14.67	-88.17
Equity	10.46	10.46	10.46	0	10.46	10.46
OPM	30.05	34.67	31.33	34.61	26.30	31.72
Net Profit	61.19+43.7%	90.02	67.78	62.90	42.57	263.27
NPM	22.36	26.37	23.52	25.46	19.56	23.76
EPS	5.85+43.7%	8.60	6.48	6.01	4.07	25.17

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24
Revenue	1,055.07-12.1%	1,200.09+18.0%	1,016.94
Other Income	52.73	44.45	33.78
Total Income	1,107.80-11.0%	1,244.53+18.4%	1,050.72
Expenditure	-753.09-0.6%	-748.66-16.7%	-641.53
Interest	-0.23	-0.53	-2.55
PBDT	0	0	0
EBITDA	376.54-25.6%	506.33+17.3%	431.55
Depreciation	-74.33	-54.37	-53.59
EBIT	302.21-33.1%	451.96+19.6%	377.96
PBT	351.43-29.1%	495.88+21.2%	409.19
Tax	-88.17	-122.91	-104.46
Equity	10.46	10.46	0
OPM (%)	31.72	39.84	39.00
Net Profit	263.27-29.4%	372.96+22.4%	304.73
NPM (%)	23.76	29.97	29.00
EPS (Rs)	25.17-29.4%	35.65+22.4%	29.13
CEPS	25.17	35.65	29.13

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	257.49+26.2%	326.08	277.77	247.06	203.99	1,054.89
Other Income	12.83	15.35	9.98	13.35	13.68	52.36
Total Income	270.31+24.2%	341.43	287.74	260.41	217.67	1,107.25
Interest	0.04	0.08	0.08	0.06	0.06	0.28
Expenditure	-193.25-20.5%	-227.18	-197.61	-177.02	-160.43	-762.23
PBDT	0	0	0	0	0	0
EBITDA	82.38+34.2%	118.52	98.99	88.49	61.40	367.40
Depreciation	-18.10	-19.54	-18.75	-18.39	-17.78	-74.46
EBIT	64.28+47.4%	98.98	80.24	70.10	43.62	292.94
PBT	77.07+34.6%	114.25	86.85	83.39	57.24	341.74
Tax	-20.65	-25.61	-22.51	-22.62	-14.67	-85.42
Equity	10.46	10.46	0	0	10.46	10.46
OPM	28.51	33.46	30.18	32.02	26.30	30.86
Net Profit	57.70+31.0%	88.47	63.64	63.06	44.06	259.23
NPM	21.35	25.91	22.12	24.22	20.24	23.41
EPS	5.52+31.1%	8.46	6.08	6.03	4.21	24.78

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24
Revenue	1,054.89-12.1%	1,200.09+18.0%	1,016.94
Other Income	52.36	44.45	33.78
Total Income	1,107.25-11.0%	1,244.53+18.4%	1,050.72
Expenditure	-762.23-1.8%	-748.66-16.7%	-641.53
Interest	-0.28	-0.53	-2.55
PBDT	0	0	0
EBITDA	367.40-27.4%	506.33+17.3%	431.55
Depreciation	-74.46	-54.37	-53.59
EBIT	292.94-35.2%	451.96+19.6%	377.96
PBT	341.74-31.1%	495.88+21.2%	409.19
Tax	-85.42	-122.91	-104.46
Equity	10.46	10.46	0
OPM (%)	30.86	39.84	38.94
Net Profit	259.23-30.2%	371.64+20.6%	308.10
NPM (%)	23.41	29.86	29.32
EPS (Rs)	24.78-30.2%	35.52+20.6%	29.45
CEPS	24.78	35.52	29.45

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	7.55	24 Jul 2026
2025	Final Dividend	10.7	03 Sep 2025
2024	Final Dividend	8.75	21 Jun 2024

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split